Results 1 to 10 of about 8,274 (166)

Gut Microbiota and Associated Mucosal Immune Response in Eosinophilic Granulomatosis with Polyangiitis (EGPA) [PDF]

Biomedicines, 2022
Eosinophilic granulomatosis with polyangiitis (EGPA) is an anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis. A genome-wide association study showed a correlation between ANCA-negative EGPA and variants of genes encoding proteins with ...
Elena Niccolai, Alessandra Bettiol, Simone Baldi, Elena Silvestri, Leandro Di Gloria, Federica Bello, Giulia Nannini, Federica Ricci, Maria Nicastro, Matteo Ramazzotti, Augusto Vaglio, Gianluca Bartolucci, Giacomo Emmi, Amedeo Amedei, Domenico Prisco   +14 more
doaj   +2 more sources

Genetic associations of eosinophilic granulomatosis with polyangiitis in the Japanese population: exploring similarities and differences with European populations [PDF]

RMD Open
Objectives Eosinophilic granulomatosis with polyangiitis (EGPA) is classified as a subtype of anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV).
Takayuki Sumida, Aya Kawasaki, Ken-ei Sada, Fumio Hirano, Shigeto Kobayashi, Kenji Nagasaka, Takahiko Sugihara, Kunihiro Yamagata, Hiroshi Hashimoto, Hirofumi Makino, Yoshihiro Arimura, Masayoshi Harigai, Naoyuki Tsuchiya, Isao Matsumoto, Yuya Kondo, Noriyoshi Ogawa, Hajime Kono, Naoto Tamura, Kumiko Shimoyama, Nobuyuki Ono, Takashi Higuchi, Yuka Kawamura, Makio Kusaoi, Kenji Itoh, Takashi Fujimoto, Tomoaki Higuchi, Ikue Ito-Naito, Mina Sato, Keita Yamashita   +28 more
doaj   +2 more sources

Eosinophilic granulomatosis polyangiitis (EGPA) complicated with periaortitis, precipitating role of dupilumab? A case report a review of the literature

RMD Open, 2023
Eosinophilic granulomatosis with polyangiitis (EGPA) is an ANCA-associated vasculitis that affects small size vessels. Only four cases of periaortitis associated with EGPA have been reported in the literature.
Patrice Cacoub, David Saadoun, Alexandre Le Joncour, Martine Kai, Pierre-Adrien Vion, Samia Boussouar   +5 more
doaj   +2 more sources

Identifying patient profiles to personalize care and improve quality of life in EGPA patients: a national cross-sectional survey [PDF]

Journal of Patient-Reported Outcomes
Background Eosinophilic granulomatosis with polyangiitis (EGPA) is a rare, chronic disease that significantly affects quality of life (QoL). Despite improved survival, many patients experience persistent symptoms and complex care needs.
Francesca Romana Torracca, Roberto Padoan, Giacomo Emmi, Lara Bernardi, Maria Rosaria Mollo, Omar Shalby, Fabio Tedone, Davide Cafiero, Eugenia Durante   +8 more
doaj   +2 more sources

Case Report: From misdiagnosis to successful treatment using mepolizumab in ANCA-negative severe EGPA—clinical lessons in eosinophil-targeted therapy [PDF]

Frontiers in Medicine
This paper presents the complex diagnostic course and treatment of a 33-year-old female patient with anti-neutrophil cytoplasmic antibodies (ANCA)-negative eosinophilic granulomatosis with polyangiitis (EGPA).
Ju-Zhang Li, Si-Yao Guan, Qiao-Zhen Wu, Jiang-Nan Zheng   +3 more
doaj   +2 more sources

Identification of a diagnostic metabolomic fingerprint in plasma for eosinophilic granulomatosis with polyangiitis. [PDF]

PLoS ONE
ObjectiveEosinophilic granulomatosis with polyangiitis (EGPA) was a rare systemic vasculitis characterized by eosinophilia, asthma, and necrotizing vasculitis.
Songsen Su, Yanfang Lin
doaj   +2 more sources

Distinct features of hypereosinophilic syndrome with neuropathy from eosinophilic granulomatosis with polyangiitis

Frontiers in Neurology, 2022
Background and objectivesHypereosinophilic syndrome (HES) and eosinophilic granulomatosis with polyangiitis (EGPA) have overlapping clinical considerations, which frequently involve peripheral neuropathy.
Hiroki Takeuchi, Kazuyuki Kawamura, Teruaki Kawasaki, Nobuyuki Oka, Nobuyuki Oka   +4 more
doaj   +1 more source

Effective treatment with mepolizumab in a patient with severe eosinophilic granulomatosis with polyangiitis complicated with small intestine perforation

Respiratory Medicine Case Reports, 2023
Eosinophilic granulomatosis with polyangiitis (EGPA) is systemic vasculitis caused by eosinophilia affecting small to medium-sized blood vessels, which damages the organs.
Mari Sato, Masakiyo Yatomi, Ikuo Wakamatsu, Shogo Uno, Chiharu Hanazato, Tomomi Masuda, Koichi Yamaguchi, Haruka Aoki-Saito, Norimitsu Kasahara, Yosuke Miura, Hiroaki Tsurumaki, Kenichiro Hara, Yasuhiko Koga, Noriaki Sunaga, Takuhisa Okada, Hayato Ikota, Takeshi Hisada, Toshitaka Maeno   +17 more
doaj   +1 more source

Computed tomography findings of paranasal sinuses in patients with eosinophilic granulomatosis with polyangiitis: Comparison with other eosinophilic sinus diseases and clinical relevance of their severity

Allergology International, 2023
Background: Although paranasal sinuses are one of the most representative organs affected by eosinophilic granulomatosis with polyangiitis (EGPA), they have not been studied sufficiently.
Maki Iwata, Yuma Fukutomi, Yuto Hamada, Yuto Nakamura, Kentaro Watai, Yosuke Kamide, Toyota Ishii, Masami Taniguchi, Kiyoshi Sekiya   +8 more
doaj   +1 more source

Symposium 10: Spotting EGPA from Asthma Populations and How Co-Care Works Between Rheumatology and Respiratory Physicians: A Case Sharing

Journal of Clinical Rheumatology and Immunology, 2023
Eosinophilic Granulomatosis with Polyangiitis (EGPA), formerly known as Churg-Strauss syndrome, is a rare systemic vasculitis characterized by asthma, eosinophilia, and vasculitic organ involvement.
Ping-Hung KUO
doaj   +1 more source